日本語English简体中文 繁體中文

4506 Sumitomo Pharma Co.,Ltd.住友ファーマTSE Prime / Pharmaceuticals

0 posts

Sumitomo Pharma Co.,Ltd. (4506) at a glance

Code
4506
Company
Sumitomo Pharma Co.,Ltd.
Local name
住友ファーマ
Market
TSE Prime
Sector
Pharmaceuticals
Share price
¥1,820 -76.0 (-4.01%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Sumitomo Pharma Co.,Ltd. (4506) Stock Price History

Sumitomo Pharma Co.,Ltd. closed at ¥1,820 on Nov 20, 2026, −3.5% over 1 month, −32.7% over 1 year.

2026-10-30 2027年3月期第2四半期(中間期)決算短信〔IFRS〕(連結) / 2027年3月期第2四半期(中間期)連結業績予想と実績との差異および通期連結業績予想… / 2027年3月期期末配当予想の修正に関するお知らせ¥2,079¥1,820Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥2,079Nov 5
1-Month Low¥1,820Nov 20
1-Week Change−10.3%vs Nov 13
1-Month Change−3.5%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥96,474 today (−3.5%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −3.5%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥1,820−76−4.01%
Nov 19 (Thu)¥1,896+2+0.11%
Nov 18 (Wed)¥1,894−76.5−3.88%
Nov 17 (Tue)¥1,970−48−2.38%
Nov 16 (Mon)¥2,018−10−0.49%
Nov 13 (Fri)¥2,028+54.5+2.76%
Nov 12 (Thu)¥1,974+39.5+2.04%
Nov 11 (Wed)¥1,934−4.5−0.23%
Nov 10 (Tue)¥1,939+24+1.25%
Nov 9 (Mon)¥1,915+76.5+4.16%
2026-10-30 2027年3月期第2四半期(中間期)決算短信〔IFRS〕(連結) / 2027年3月期第2四半期(中間期)連結業績予想と実績との差異および通期連結業績予想… / 2027年3月期期末配当予想の修正に関するお知らせ¥2,079¥1,412Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥2,079Nov 5
3-Month Low¥1,412Aug 21
1-Month Change−3.5%vs Oct 20
3-Month Change+24.2%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥124,198 today (+24.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved +24.2%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥1,820−76−4.01%
Nov 19 (Thu)¥1,896+2+0.11%
Nov 18 (Wed)¥1,894−76.5−3.88%
Nov 17 (Tue)¥1,970−48−2.38%
Nov 16 (Mon)¥2,018−10−0.49%
Nov 13 (Fri)¥2,028+54.5+2.76%
Nov 12 (Thu)¥1,974+39.5+2.04%
Nov 11 (Wed)¥1,934−4.5−0.23%
Nov 10 (Tue)¥1,939+24+1.25%
Nov 9 (Mon)¥1,915+76.5+4.16%
2026-10-30 2027年3月期第2四半期(中間期)決算短信〔IFRS〕(連結) / 2027年3月期第2四半期(中間期)連結業績予想と実績との差異および通期連結業績予想… / 2027年3月期期末配当予想の修正に関するお知らせ¥2,079¥1,230May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥2,079Nov 5
6-Month Low¥1,230Aug 4
3-Month Change+24.2%vs Aug 20
6-Month Change+19.7%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥119,704 today (+19.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved +19.7%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥1,820−3.4%
Oct 2026¥1,885+15.9%
Sep 2026¥1,627+4.7%
Aug 2026¥1,554+24.5%
Jul 2026¥1,248−16.9%
Jun 2026¥1,501−7.5%
May 2026¥1,623−5.6%
2026-10-30 2027年3月期第2四半期(中間期)決算短信〔IFRS〕(連結) / 2027年3月期第2四半期(中間期)連結業績予想と実績との差異および通期連結業績予想… / 2027年3月期期末配当予想の修正に関するお知らせ¥3,184¥1,230Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥3,184Feb 17
52-Week Low¥1,230Aug 4
Year to Date−21.5%vs Dec 30
From 52-Week High−42.9%Feb 17

If you had invested ¥100,000 1 year ago, it would be worth ¥67,339 today (−32.7%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −32.7%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥1,820−3.4%
Oct 2026¥1,885+15.9%
Sep 2026¥1,627+4.7%
Aug 2026¥1,554+24.5%
Jul 2026¥1,248−16.9%
Jun 2026¥1,501−7.5%
May 2026¥1,623−5.6%
Apr 2026¥1,720−17.2%
Mar 2026¥2,076−17.8%
Feb 2026¥2,524+9.9%
Jan 2026¥2,297−0.9%
Dec 2025¥2,318−15.1%
Nov 2025¥2,730―
¥2,910¥300Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥2,910Jan 9, 2026
3-Year Low¥300May 20, 2024
Annualized Return+54.4%
Max Drawdown−57.1%

If you had invested ¥100,000 3 years ago, it would be worth ¥368,320 today (+268.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved +268.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,820−21.5%
2025¥2,318―
¥2,910¥300Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥2,910Jan 9, 2026
5-Year Low¥300May 20, 2024
Annualized Return+4.9%
Max Drawdown−79.1%

If you had invested ¥100,000 5 years ago, it would be worth ¥126,794 today (+26.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved +26.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,820−21.5%
2025¥2,318―
¥3,700¥305Feb 1, 2000Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥3,700Nov 2018
All-Time Low¥305May 2024
Total Change+112.8%vs Feb 2000
Annualized Return+2.9%

If you had invested ¥100,000 in Feb 2000, it would be worth ¥212,807 today (+112.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +177.5%, while this stock moved +112.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,820−21.5%
2025¥2,318+311.7%
2024¥563+20.8%
2023¥466−53.4%
2022¥999−24.6%
2021¥1,325−13.0%
2020¥1,523−28.5%
2019¥2,130−39.1%
2018¥3,495+108.8%
2017¥1,674−16.7%
2016¥2,010+40.5%
2015¥1,431+22.2%
2014¥1,171−28.8%
2013¥1,645+58.9%
2012¥1,035+18.0%
2011¥877+18.8%
2010¥738−24.4%
2009¥976+17.3%
2008¥832+1.7%
2007¥818−40.9%
2006¥1,384+25.2%
2005¥1,105+7.2%
2004¥1,031+40.3%
2003¥735−25.9%
2002¥992−25.4%
2001¥1,330−29.6%
2000¥1,890―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2000). Please check the latest prices before trading.

Sumitomo Pharma Co.,Ltd. (4506) financial indicators

PER
8.6
PBR
1.89
ROE
21.96%
Dividend yield
0.82%

See all financial indicators for Sumitomo Pharma Co.,Ltd. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Sumitomo Pharma Co.,Ltd. (4506)

Business overview

The company is a pharmaceutical maker that manufactures, purchases and sells prescription drugs, and its parent is Sumitomo Chemical. It makes and sells prescription drugs in Japan and North America, and through joint ventures with Sumitomo Chemical it provides contract process development and manufacturing for regenerative and cell medicine and researches regenerative medicine products. In Asia, a joint venture with Marubeni Global Pharma handles prescription drugs.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Pharmaceuticals (79 companies)

Dividend yield0.82%No. 37 in the sector (highest first); median 2.97%
PER8.6xBelow the sector median of 16.5x (No. 3 from the lowest)
PBR1.89xAbove the sector median of 1.86x (No. 40 from the lowest)
ROE21.96%No. 1 in the sector (highest first); median 4.17%
Market cap¥816.2 bnNo. 10 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥3,1842/17
52-week low¥1,2308/4
Current position30.2%Where the low is 0% and the high is 100% (close on 11/20: ¥1,820)
Year to date-21.5%No. 46 of 77 in the sector (best first)
1 year-32.7%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers1 timesLatest: 10/15 (No. 9)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (5).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Sumitomo Pharma Co.,Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English